| Literature DB >> 19114007 |
Juanita A Haagsma1, Arie H Havelaar, Bas Mf Janssen, Gouke J Bonsel.
Abstract
BACKGROUND: Burden of disease estimates, which combine mortality and morbidity into a single measure, are used increasingly for priority setting in disease control, prevention and surveillance. However, because there is no clear exclusion criterion for highly prevalent minimal disease in burden of disease studies its application may be restricted. The aim of this study was to apply a newly developed relevance criterion based on preferences of a population panel, and to compare burden of disease estimates of five foodborne pathogens calculated with and without application of this criterion.Entities:
Year: 2008 PMID: 19114007 PMCID: PMC2655281 DOI: 10.1186/1478-7954-6-7
Source DB: PubMed Journal: Popul Health Metr ISSN: 1478-7954
Statistics of the population panel
| Age (in years) | 51.2 [21–79] |
| Sex | |
| Male | 41 (38%) |
| Female | 66 (62%) |
| Educational level | |
| Low | 22 (21%) |
| Middle | 43 (40%) |
| High | 41 (38%) |
| Unknown | 1 (1%) |
| Disease experience | |
| Yes | 55 (51%) |
| No | 51 (48%) |
| Unknown | 1 (1%) |
Mean VAS weights and mean and median TTO weights, per health state
| Gastroenteritis, mild, 1 day | 51 | 0.036 | 0 | 0.002 | 0.01 | 88 |
| Gastroenteritis, mild, 5 days | 53 | 0.102 | 0 | 0.010 | 0.04 | 60 |
| Gastroenteritis, moderate, 10 days | 107 | 0.130 | 0.005 | 0.015 | 0.04 | 26 |
| Gastroenteritis, severe, 7 days | 53 | 0.231 | 0.008 | 0.025 | 0.05 | 25 |
| Gastroenteritis, severe, 14 days | 51 | 0.295 | 0.011 | 0.041 | 0.07 | 17 |
| Gastroenteritis, chronic, 6 months | 53 | 0.368 | 0.058 | 0.099 | 0.11 | 8 |
| Guillain-Barré syndrome, F1, whole year | 51 | 0.185 | 0.008 | 0.044 | 0.09 | 40 |
| Guillain-Barré syndrome, F2, whole year | 107 | 0.420 | 0.077 | 0.137 | 0.18 | 7 |
| Guillain-Barré syndrome, F3, whole year | 53 | 0.545 | 0.153 | 0.215 | 0.23 | 2 |
| Guillain-Barré syndrome, F4, whole year | 51 | 0.700 | 0.252 | 0.367 | 0.32 | 2 |
| Guillain-Barré syndrome, F5, whole year | 53 | 0.722 | 0.403 | 0.460 | 0.31 | 0 |
| Reactive arthritis, mild, 1 week | 51 | 0.107 | 0 | 0.004 | 0.01 | 68 |
| Reactive arthritis, mild, 6 weeks | 53 | 0.197 | 0.011 | 0.023 | 0.03 | 25 |
| Reactive arthritis, moderate, 6 months | 53 | 0.447 | 0.058 | 0.115 | 0.13 | 8 |
| Reactive arthritis, severe, 6 months | 51 | 0.503 | 0.153 | 0.186 | 0.16 | 4 |
| HUS, moderate, 1 month | 53 | 0.279 | 0.022 | 0.056 | 0.08 | 13 |
| HUS, severe, 1 month | 51 | 0.481 | 0.038 | 0.110 | 0.19 | 0 |
| Renal failure, whole year | 51 | 0.628 | 0.252 | 0.328 | 0.25 | 0 |
| Crohn disease, 6 months | 51 | 0.347 | 0.067 | 0.105 | 0.12 | 4 |
| Colitis ulcerosa, 6 months | 53 | 0.492 | 0.115 | 0.154 | 0.15 | 7 |
a percentage of participants that were not willing to trade-off any time in order to be restored from the health state.
b for a detailed description of the five health states of patients with Guillain-Barré syndrome, see Havelaar et al. [8]
Median TTO weights of 10 health states valued in two preceding panel studies, by health state
| Common cold, 7 days | 101 | 0 | 85 | 140 | 0 | 81 |
| Cystitis, 2 weeks | 102 | 0.003 | 47 | 64 | 0.005 | 27 |
| Rhinitis, 17 weeks | 102 | 0.003 | 38 | 64 | 0.019 | 28 |
| Eczema, whole year | 102 | 0.019 | 16 | 64 | 0.044 | 11 |
| Gastritis, 4 weeks | 101 | 0.005 | 37 | 64 | 0.019 | 16 |
| Onychomycosis, whole year | 102 | 0 | 83 | 63 | 0 | 60 |
| Osteoporosis, whole year | 102 | 0.003 | 45 | 142 | 0.003 | 36 |
| Otitis, 2 weeks | 101 | 0.003 | 40 | 64 | 0.010 | 44 |
| Superficial injury, 4 weeks | 32 | 0 | 53 | 142 | 0 | 72 |
| Open wound, 4 weeks | 34 | 0.005 | 41 | 47 | 0.003 | 49 |
a %0 = the percentage of participants that were not willing to trade-off any time in order to be restored from the health state
Incidence and disease burden calculated with and without the preference-based relevance criterion (RC), by pathogen
| Gastroenteritis | 472,000 | 55 | 2885 | 2940 | 121 | 175 |
| Gastroenteritis | 190,000 | 110 | 1217 | 1327 | 176 | 287 |
| Gastroenteritis | 59,400 | 390 | 420 | 810 | 148 | 538 |
| Guillain-Barré syndrome | 60 | 35 | 150 | 185 | 150 | 185 |
| Reactive arthritis | 864 | - | 40 | 40 | 40 | 40 |
| Inflammatory Bowel Disease | 22 | - | 102 | 102 | 102 | 102 |
| Total | 1137 | 865 | ||||
| Gastroenteritis | 35,400 | 440 | 255 | 697 | 77 | 517 |
| Reactive arthritis | 460 | - | 17 | 17 | 17 | 17 |
| Inflammatory Bowel Disease | 7 | - | 33 | 33 | 33 | 33 |
| Total | 747 | 567 | ||||
| Gastroenteritis | 1,300 | 6 | 13 | 19 | 7 | 13 |
| Hemolytic Uremic Syndrome | 20 | 76 | 25 | 101 | 25 | 101 |
| Total | 120 | 114 | ||||